Drugs that Affect Bone and Mineral Homeostasis Flashcards
High dose PTH causes?
Increased bone resorption, hypercalcemia, and hyperphosphatemia
Low intermittent doses of PTH causes?
Net increase in bone formation
Signs and symptoms of excess PTH
Painful bones
Renal stones
Abdominal groans
Psychiatric overtones
Used in rickets and osteomalacia
Ergocalciferol
Cholecalciferol
Used in secondary hyperparathyroidism in CKD to lower serum PTH
Calcitriol (AE: causes hypercalcemia)
Paricalcitol: rarely precipitates hypercalcemia
Cinacalcet: suppresses PTH synthesis and release
Used in psoriasis
Calcipotriene
First line drug for Paget’s disease of bone
Calcitonin
Alendronate (Bisphosphonate)
Pamidronate- most useful for the treatment of hypercalcemia in Paget’s disease
Used in hyperphosphatemia in CKD hypoparathyroidism, and Vitamin D intoxication
Sevelamer
phosphate binding resin
Recombinant PTH used for the treatment of osteoporosis; acts through PTH receptors to produce a net increase in bone formation
Teriparatide
MOA of denosumab
Binds to RANKL and prevents it from stimulating osteoclast differentiation and function
Used for hyperparathyroidism
Cinacalcet (Calcimimetic)- activates the calcium-sensing receptor
Routinely added to calcium supplements and milk for the purpose of preventing rickets in children and osteomalacia in adults
Cholecalciferol
Long term use of this drug causes osteoporosis
Glucocorticoids
MOA of bisphosphonates (eg. alendronate)
Suppresses the activity of osteoclasts and inhibits bone resorption
Used for osteoporosis in postmenopausal women
Raloxifene (estrogen agonist effect in bones)